Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03876743 · ClinicalTrials.gov registry record · NA
Opiates Prescribing for Knee Arthroscopies and ACL Reconstruction
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 201
- Enrollment target
NCT03876743: Completed NA study, sponsored by Northwestern University.
NCT03876743 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 201 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03876743, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 201 participants
- Enrollment target
Study Summary
The purpose of the study is to determine if opiates are required to achieve adequate analgesia after knee arthroscopy and ACL reconstruction in outpatient surgery. The investigators hypothesize that patients are frequently prescribed more opiates than are needed after surgery, resulting in excess medications that are at risk for misuse, diversion and contribution to the opioid epidemic.
Primary Outcome
2 hours post-op; minimum score: 0 = no pain, maximum score: 10 = worst imaginable pain; lower value is better
Interventions
- OTHER Group 1-Knee Arthroscopy
- OTHER Group 2-Knee Arthroscopy
- OTHER Group 1-ACL reconstruction
- OTHER Group 2-ACL reconstruction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2018-03-26 |
| Est. Completion | 2020-07-08 |
| Phase | NA |
What the finished NCT03876743 record still lists
NCT03876743 is an interventional study that assigns participants to a tested intervention. The registered 201 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 4 interventions - of which Group 1-Knee Arthroscopy is the first listed.
NCT03876743 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03876743 about?
NCT03876743 is a clinical study titled "Opiates Prescribing for Knee Arthroscopies and ACL Reconstruction". The purpose of the study is to determine if opiates are required to achieve adequate analgesia after knee arthroscopy and ACL reconstruction in outpatient surgery. The investigators hypothesize that patients are frequently prescribed more opiates than are needed after surgery, resulting in excess m...
What is the current status of trial NCT03876743?
This trial is currently completed. It is a NA study. The enrollment target is 201 participants. The study started on 2018-03-26. Estimated completion is 2020-07-08.
What interventions are being tested in trial NCT03876743?
The interventions under investigation include: Group 1-Knee Arthroscopy (OTHER), Group 2-Knee Arthroscopy (OTHER), Group 1-ACL reconstruction (OTHER), Group 2-ACL reconstruction (OTHER).
Who is sponsoring clinical trial NCT03876743?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03876743's enrollment target sits among peer trials
201 506th of 2000 higher than 1,495 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04422652 · 201 participants · Phase 2
Combination of Novel Therapies for CKD Comorbid Depression
- NCT05327114 · 201 participants · Phase 2
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- NCT06099769 · 201 participants · Phase 2
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
- NCT06274528 · 201 participants · Phase 2
DORA and LP in Alzheimer's Disease Biomarkers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI